Work

4510 POSTER A phase 2 trial of sunitinib in bevacizumab-refractory metastatic renal cell carcinoma (mRCC): updated results and analysis of circulating biomarkers

Year: 2007

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(07)71141-2

Authors: T.E. Hutson, D.J. George, M.D. Michaelson, J.E. Rosenberg, R.M. Bukowski, J.A. Sosman, W.M. Stadler, K. Margolin, B.I. Rini

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2094908426

Cites:

Cited by: 2

Related to: 10